Supplementary Figure 14 from A Phase I Study of FHD-286, a Dual BRG1/BRM (SMARCA4/SMARCA2) Inhibitor, in Patients with Advanced Myeloid Malignancies
Authors:
- Courtney D. DiNardoCDCourtney D. DiNardo
- Amir T. FathiAFAmir T. Fathi
- Ashwin KishtagariAKAshwin Kishtagari
- Kapil N. BhallaKBKapil N. Bhalla
- Alfonso Quintás-CardamaAQAlfonso Quintás-Cardama
- Sarah A. ReillySRSarah A. Reilly
- Caroline AlmonCACaroline Almon
- Caitlin PatriquinCPCaitlin Patriquin
- Salah NabhanSNSalah Nabhan
- Kathleen HealyKHKathleen Healy
- Denice HickmanDHDenice Hickman
- Michael P. CollinsMCMichael P. Collins
Open Access
- 13 June 2025
- other
- Published by American Association for Cancer Research (AACR)